| Oct 28 |
AbbVie strengthens CNS research with $1.4B buyout of Aliada Therapeutics
|
| Oct 28 |
AbbVie's Bold $1.4 Billion Bet: The Alzheimer's Breakthrough Investors Have Been Waiting For
|
| Oct 28 |
AbbVie Acquires Aliada Therapeutics for $1.4 Billion to Boost Neuroscience Portfolio
|
| Oct 28 |
AbbVie to Acquire Aliada Therapeutics for $1.4 Billion
|
| Oct 28 |
Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?
|
| Oct 28 |
Top Midday Stories: Boeing Launches Public Offerings; McDonald's Quarter Pounder to Return to Menus This Week
|
| Oct 28 |
AbbVie is buying an Alzheimer's drug for more than $1 billion
|
| Oct 28 |
32-Year-Old Who Reached $600 a Month Dividend Income After 5 Years of Investing Shares Portfolio Details: Top 8 Stocks and ETFs
|
| Oct 28 |
AbbVie to buy Aliada Therapeutics for $1.4B in cash
|
| Oct 28 |
AbbVie to acquire a J&J-backed brain drugmaker for $1.4B
|
